title: Effect of trifluoperazine on CSF and plasma HVA levels in schizophrenic subjects.
authors.forename: R
authors.initials: R
authors.lastname: Sharma
authors.forename: J I
authors.initials: JI
authors.lastname: Javaid
authors.forename: P
authors.initials: P
authors.lastname: Janicak
authors.forename: J
authors.initials: J
authors.lastname: Comaty
authors.forename: J M
authors.initials: JM
authors.lastname: Davis
authors.forename: K
authors.initials: K
authors.lastname: Faull
mesh_terms: D000328:Adult; D004298:Dopamine / Q000378:metabolism; D005260:Female; D006719:Homovanillic Acid / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism*; D006801:Humans; D008297:Male; D012559:Schizophrenia / Q000097:blood / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D014268:Trifluoperazine / Q000627:therapeutic use*
chemical_list: D014268:Trifluoperazine; D004298:Dopamine; D006719:Homovanillic Acid